op operatio ionaliz izin ing b bpci i adva vanced may
play

OP OPERATIO IONALIZ IZIN ING B BPCI I ADVA VANCED MAY 2018 - PowerPoint PPT Presentation

OP OPERATIO IONALIZ IZIN ING B BPCI I ADVA VANCED MAY 2018 2018 Intr troducti tions Steve F Farm rmer, M , MD, F , FACC, F , FASE Senior Medical Officer CMS Innovation Center Practicing Cardiologist Elizabeth Curri


  1. OP OPERATIO IONALIZ IZIN ING B BPCI I ADVA VANCED MAY 2018 2018

  2. Intr troducti tions Steve F Farm rmer, M , MD, F , FACC, F , FASE • Senior Medical Officer • CMS Innovation Center • Practicing Cardiologist Elizabeth Curri Currier, M , MBA/MPH, L LSSGB, F , FACMPE • Physician Practice Administrator • Senior Improvement Advisor • CMS Innovation Center 2

  3. Webcas ast Ou Outline • The CMS Innovation Center • Review of BPCI Advanced Features • Application to the Model • Participation in the Model Common Challenges • Strategies for Success • • CMS Innovation Center Partnership • Reconciliation Process • Summary and Conclusions 3

  4. INTROD ODUCTION ON The CMS Innovation Center and BPCI Advanced 4

  5. The CM he CMS I Inn nnovation Cen Center er • As part of the Centers for Medicare & Medicaid Services (CMS), the CMS Innovation Center provides national leadership in the transition from volume to value • The center tests innovative payment and service delivery models that reduce costs while preserving or enhancing quality • Guiding principles Patient centered care • Provider choice and incentives • Choice and competition in the market • Transparent model design and evaluation • Benefit design and price transparency • Small scale testing • 5

  6. Model Sce cenarios f for S Succe ccess 1 Qua uality Cost 2 Qua uality Cost 3 Bes est Case Qua uality Cost 6

  7. REVI EVIEW EW Bundled Payments for Care Improvement Advanced 7

  8. BPC PCI A Advanced T Tests a a Different Payment A Approac ach Shifts emphasis from in indiv ivid idual l Establishes an servi vice ces towards a coordinated “accountable p e party” clinic ical e al episod ode Clinical episodes are assessed on the quality ty a and c cost of care 8

  9. BPC PCI A Advanced i is Different T Than B BPC PCI • Streamline ined de design One model, 90-day episode period • Single risk track • Inpatient and Outpatient episodes • Preliminary target prices provided in advance • Payment tied to performance on quality measures • • Greater focus on ph physic icia ian n eng ngagement a and l nd learni ning ng • Designed as an Advanc nced A d APM under the Quality Payment Program 9

  10. Who L Leads Clinical Ep Episodes? Physician G n Group up Ac Acut ute C Care Ho e Hospitals s Practices ( s (PGP GPs) (ACHs Hs) 10

  11. Participants M May Work w with a a Convener A C Conven ener er is a a Medicare-enrolled pr provide der o or suppl upplier or a an n entity t tha hat is no not enr nrolle led i d in n Medic dicare. Conven ener ers m may: • Facilitate participation by smaller PGPs or ACHs • Provide data and analytic feedback • Offer logistical and operational support • Bear financial risk to CMS under the Model 11

  12. Quality M Measures Will include clai laims-based ed Addit ition ional me al meas asures with measures es t through gh 2020 varying reporting mechanisms may be added in the future 12

  13. Initial Quality M Measures Qua uality m measu sures es for: All-cause Hospital Readmission Measure Al All (Natio ional l Qualit lity Forum [NQF] #1789) 1789) Clinical Care Plan Epi piso sodes des (NQF # #0326) 0326) Perioperative Care—Selection of Prophylactic Antibiotic: First or Second Generation Cephalosporin (NQF # #0268) 0268) Hospital-Level Risk-Standardized Complication Rate (RSCR) Following Elective Primary Total Hip Arthroplasty (THA) and/or Total Knee Arthroplasty (TKA) (NQF # #1550) 1550) Spec ecific Clinical Hospital 30-Day, All-Cause, Risk-Standardized Mortality Rate (RSMR) Following Coronary Artery Bypass Graft Surgery Epi piso sodes des (NQF # #2558) 2558) Excess Days in Acute Care after Hospitalization for Acute Myocardial Infarction (NQF QF #2881) 2881) AHRQ Patient Safety Indicators (PS PSI I 90) 13

  14. Setting B Bench chmark P Price ces Ph Physic ician Group up P Practice Hospital al’s Benchmark P ark Price: (PG PGP) P) Benc nchmark Price: Patient case-mix 1. 1. Anchored on hospital Peer group trends 2. 2. Accounts for PGP– specific historical Historic efficiency 3. practice pattern 14

  15. PGP P PG P Prici cing Ur Urban an Acad ademic ic M Medic ical al Rura ral Cente ter ( (AMC) ACH: $20,000 PGP: $22,000 ACH: $18,000 ACH: $25,000 PGP PGP PGP: $20,000 PGP: $27,000 KEY POI POINTS 1. PGPs may practice at multiple hospitals 2. Hospital pricing varies 3. Limited time PGP adjustment, anchored on hospital price 15

  16. BPCI BP CI A Adv dvanc anced ed Prec eced eden ence R Rul ules es 1 At Attendi nding ng P PGP 2 Opera rating ng P PGP 3 ACHs Hs 16

  17. Pati tient A Attr tributi tion: M Multi tiple P PGPs, B Both th Participating i in Pneumonia Clinical Ep Episode Clinic ical E Epis isode Attribution Partic icip ipatin ing P g PGP 1 PGP1 PG P1 Non-Partic icip ipatin ing A g ACH Non-Partic No icip ipatin ing PGP GP 2 2 KEY POINT NTS Partic icip ipatin ing g 1. Multiple PGPs may exist at an PGP GP 3 3 ACH PG PGP3 P3 2. All PGPs need not participate 3. Attending identified through UB-04 and Part B Claim 17

  18. Patient A Attribution: A ACH and Multiple PG PGPs, Participating i in Pneumonia Clinical Ep Episode Clinic ical E Epis isode Attribution Partic icip ipatin ing P g PGP 1 PGP1 PG P1 Partic icip ipatin ing A ACH No Non-Partic icip ipatin ing PGP GP 2 2 ACH Partic icip ipatin ing g KEY POINT NTS PGP GP 3 3 1. ACHs and PGPs may participate 2. If ACH participates, all clinical PGP3 PG P3 episodes are in the model 18

  19. Patient A Attribution: A ACH and Multiple PGPs, D Dif ifferent C Clin linic ical Epis isodes Clinic ical E Epis isode Attribution Partic icip ipatin ing P g PGP 1 PGP1 PG P1 Partic icip ipatin ing A ACH Non-Partic No icip ipatin ing PGP GP 2 2 ACH Partic icip ipatin ing g KEY POINT NTS PGP GP 3 3 1. PGPs and ACH may participate in different episode categories PG PGP3 P3 2. Exclusive participant would get all episodes, subject to trigger rules 19

  20. APPLICATION TO THE MODEL 20

  21. Applicants W Will Rece ceive Data i in Advance • CMS will provide preliminary target prices to applicants in May 2018 • Applicants who submit a Data Request and Attestation form o Three years of aggregate (summary) and/or raw (beneficiary line- level) Historical Claims data for the Medicare beneficiaries who would have been included in a Clinical Episode and attributed to the applicant • Convener appl pplicants receive target prices for all of their episode initiators (EIs) • No Non-convener appl pplicants receive their own target prices 21

  22. Clinical Ep Episode S Select ction • Participants will enter into an agreement with CMS May be renewed annually • Commits to selected Clinical Episodes until the start of the • following Agreement Term • Episode selections must be submitted to CMS by August 1, 1, 2018 2018 22

  23. Considerati tions f for P Parti ticipation • Are there other potential Participants for the same Clinical Episode at the same ACH? • Are there clear opportunities for improvement within the model? • Can operational investments be spread across multiple clinical episodes? ? ? • Can Participants safely assume financial risk? • Does it make sense to work with a Convener? • Would Participants qualify for incentive payments as a Qualifying APM Participant in the Quality Payment Program? 23

  24. PARTIC ICIP IPATIO ION I IN THE M E MOD ODEL EL 24

  25. Exam ample S Strategy: y: Data T Transpar arency • Utilize care management software to share data between hospital and PAC providers; include physician, hospital, and regional-level data. • Create patient dashboards with real-time data that physicians and partners can easily access. • Utilize a data analytic tool to help staff identify patients needing additional care during their SNF stay. 25

  26. Example S Str trategy: Uti tilize a a Risk k Asse Assessment T Tool • Incorporate a readmission prediction tool into your electronic health record (EHR) for both high and middle risk patients. o Use a tool, which includes a section for identifying patient risk for readmission, in tandem with "At-Risk" meetings. o Use a tool, which includes care pathways and “change in condition” tools, to manage care and prevent readmissions. o Use an index scoring tool for risk assessment of death and readmission. • Use a n analysis platform, which assists with risk assessment and discharge planning decisions. 26

  27. Exampl ple S Strategy: Redes edesign Car Care e Pa Pathway ays • Update and simplify patient forms/checklists to ease pre- screening and post-acute care transfer. Support consistent use by all providers. • Provide telephone number/toll-free hotline for patients to call with questions or concerns post-discharge to reduce readmissions. • Modify clinical pathways to incorporate therapy interventions. 27

Recommend


More recommend